N8E-83308-09859 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-04
Registered in v-safe
2021-01-04
Dose 1 — Moderna
2021-01-04
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-11
Health check-in — day 7, dose 1
Feeling: Good · Site: Redness, Swelling, Itching · None

Adult check-in
2021-01-18
Survey response — day 14, dose 1
MedDRA: Cough, Fatigue, Injection site rash, Lymphadenopathy, Rash, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activities

Free text: Worsening of spread and severity on rash on vaccinated arm (extending from deltoid to elbow) + unilateral axillary lymphadenopathy. ~48 hrs of dry cough + fatigue (COVID negative on rapid swab)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-18
Report sent to call center — day 14, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-27
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-31
Dose 2 — Moderna
2021-02-01
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-02-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Redness, Swelling, Itching · None

Adult check-in
2021-02-09
Health check-in — day 7, dose 2
Feeling: Good · Site: Redness, Itching · None

Adult check-in
2021-02-16
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-09
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-14
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-08-03
Survey response — 6 months, dose 2
MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school

Free text: Several colds

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-12-04
Dose 3 — Moderna
2022-12-01
Dose 4 — Pfizer-BioNTech
2022-12-06
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in
2022-12-06
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Redness · None

Adult check-in
2022-12-29
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2023-01-05
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2023-01-14
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-04	Moderna
2	2021-01-31	Moderna
3	2021-12-04	Moderna	No
4	2022-12-01	Pfizer-BioNTech	No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — day 14, dose 1

2021-01-18

Symptoms: Worsening of spread and severity on rash on vaccinated arm (extending from deltoid to elbow) + unilateral axillary lymphadenopathy. ~48 hrs of dry cough + fatigue (COVID negative on rapid swab)

Release 9 — 6 months, dose 2

2021-08-03

Symptoms: Several colds

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Injection site rash	✓	·	✓
SD	Lymphadenopathy	✓	✓	✓
SD	Nasopharyngitis	✓	·	✓
SD	Rash	✓	✓	✓
SD	SARS-CoV-2 test negative	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release